5H-cyclopenta[d]pyrimidines as AKT protein kinase inhibitors
US8895566B2 · kind B2 · utility
1Cited by
6References
34Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Nov 15, 2012 |
| Grant date | Nov 25, 2014 |
| Priority date | — |
| Expiry date | Feb 7, 2033 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D487/04
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Compounds of Formula I are useful for inhibiting AKT protein kinases. Methods of using compounds of Formula I and stereoisomers and pharmaceutically acceptable salts thereof, for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pathological conditions are disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.